• Activity INFORMATION

  Overview

  When a pharmacist dispenses a drug approved by the FDA, he or she can be reasonably confident that it will be safe and effective for the population that was studied in the clinical trial and can counsel the patient accordingly. But what if it is prescribed for a different (unapproved) use? Is this practice, known as off-label drug use (OLDU), permissible? How common is it? What are the risks involved? This webinar will review the practice of OLDU and discuss the role of the FDA, the prescriber, the manufacturer, and the pharmacist.  
  

  Handouts

  • Slide Document :   21135H03_2pp.pdf Download

  • Slide Document :   21135H03_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Recognize the rationale and regulatory standing for off-label prescribing.

  Characterize the legal and non-legal responsibilities of prescriber, manufacturer, and pharmacist for off-label drug use.

  Distinguish between the risks and benefits of on-label and off-label use of drugs.

  Pharmacy Technician

  Characterize the legal and non-legal responsibilities of prescriber, manufacturer, and pharmacist for off-label drug use.

  Distinguish between the risks and benefits of on-label and off-label use of drugs.

  Recognize the rationale and regulatory standing for off-label prescribing.

  Nurse

  Distinguish between the risks and benefits of on-label and off-label use of drugs.

  Characterize the legal and non-legal responsibilities of prescriber, manufacturer, and pharmacist for off-label drug use.

  Recognize the rationale and regulatory standing for off-label prescribing.

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-883436

  Universal Activity Number

  Pharmacist 0798-0000-21-135-H03-P
  Pharmacy Technician 0798-0000-21-135-H03-T
  Nurse 0798-0000-21-135-H03-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Gerald  Gianutsos, JD, PhD, BS Pharm, MS Associate Professor Emeritus, Department of Pharmaceutical Sciences, University of Connecticut School of Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).